company background image
530317 logo

Godavari Drugs BSE:530317 Stock Report

Last Price

₹107.70

Market Cap

₹811.0m

7D

-4.5%

1Y

7.3%

Updated

30 Jan, 2025

Data

Company Financials

Godavari Drugs Limited

BSE:530317 Stock Report

Market Cap: ₹811.0m

530317 Stock Overview

Manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. More details

530317 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health3/6
Dividends0/6

Rewards

Price-To-Earnings ratio (12.3x) is below the Indian market (29.3x)

Earnings grew by 80.1% over the past year

Risk Analysis

Interest payments are not well covered by earnings

Does not have a meaningful market cap (₹811M)


My Notes

Capture your thoughts, links and company narrative

Godavari Drugs Limited Competitors

Makers Laboratories

BSE:506919

₹991.3m

Biofil Chemicals and Pharmaceuticals

BSE:524396

₹863.7m

Shelter Pharma

BSE:543963

₹601.1m

Sotac Pharmaceuticals

NSEI:SOTAC

₹1.2b

Price History & Performance

Summary of share price highs, lows and changes for Godavari Drugs
Historical stock prices
Current Share Price₹107.70
52 Week High₹155.00
52 Week Low₹86.99
Beta0.93
1 Month Change-1.51%
3 Month Change-13.15%
1 Year Change7.29%
3 Year Change68.81%
5 Year Change490.14%
Change since IPO3,431.15%

Recent News & Updates

Recent updates

Shareholder Returns

530317IN PharmaceuticalsIN Market
7D-4.5%-3.4%-1.4%
1Y7.3%18.6%5.8%

Return vs Industry: 530317 underperformed the Indian Pharmaceuticals industry which returned 18.6% over the past year.

Return vs Market: 530317 exceeded the Indian Market which returned 5.8% over the past year.

Price Volatility

Is 530317's price volatile compared to industry and market?
530317 volatility
530317 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 530317 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 530317's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987111Mukund Kakanigodavaridrugs.com

Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan license and contract manufacturing services for API’s and drug intermediates.

Godavari Drugs Limited Fundamentals Summary

How do Godavari Drugs's earnings and revenue compare to its market cap?
530317 fundamental statistics
Market cap₹811.03m
Earnings (TTM)₹66.02m
Revenue (TTM)₹1.40b

12.3x

P/E Ratio

0.6x

P/S Ratio

Is 530317 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530317 income statement (TTM)
Revenue₹1.40b
Cost of Revenue₹1.04b
Gross Profit₹360.26m
Other Expenses₹294.24m
Earnings₹66.02m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)8.77
Gross Margin25.67%
Net Profit Margin4.70%
Debt/Equity Ratio141.1%

How did 530317 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 18:56
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Godavari Drugs Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research